HTX-011
HTX-011 is a pharmaceutical drug with 17 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 15 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
9
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
93.8%
15 of 16 finished
6.3%
1 ended early
0
trials recruiting
17
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen
Phase 2 Bunionectomy HTX-011 Administration Study
Phase 2B Upper Extremity Nerve Block Study
Bunionectomy Study for Postoperative Analgesia (EPOCH 1)
Pilot Herniorrhaphy Study for Postoperative Analgesia
Clinical Trials (17)
Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen
Phase 2 Bunionectomy HTX-011 Administration Study
Phase 2B Upper Extremity Nerve Block Study
Bunionectomy Study for Postoperative Analgesia (EPOCH 1)
Pilot Herniorrhaphy Study for Postoperative Analgesia
Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia
Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)
Phase 2 Herniorrhaphy Study for Opioid Elimination
Periarticular Bupivacaine + Meloxicam ER Solution Versus Standard Practice During Total Knee Arthroplasty
A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE
A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE.
A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401.
HTX-011 in Spinal Surgery
Pediatric Postoperative Analgesia Herniorrhaphy Study
HTX-011 Administration Study in Planned Caesarean Section Procedure
Herniorrhaphy Study for Opioid Elimination
A Phase 2, Two-Part Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy
All 17 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 17